Advancement in characterization of genomic alterations for improved diagnosis, treatment and prognostics in cancer.
Title | Advancement in characterization of genomic alterations for improved diagnosis, treatment and prognostics in cancer. |
Publication Type | Journal Article |
Year of Publication | 2006 |
Authors | Zhou X, Yu T, Cole SW, Wong DTW |
Journal | Expert Rev Mol Diagn |
Volume | 6 |
Issue | 1 |
Pagination | 39-50 |
Date Published | 2006 Jan |
ISSN | 1744-8352 |
Keywords | Animals, Gene Dosage, Gene Expression Profiling, Genome, Human, Humans, Molecular Diagnostic Techniques, Neoplasms, Nucleic Acid Hybridization |
Abstract | Most human cancers are characterized by genetic instabilities. These instabilities manifest themselves as a series of genetic alterations, including discrete mutations and chromosomal aberrations. With the human genome deciphered, high-throughput technologies are rapidly advancing the field to generate genome-wide gene expression and mutation profiles that are highly correlative of biologic and disease phenotypes. While recent advancement in comprehensive genomic characterization presents an unprecedented opportunity for advancing the treatment of cancer, there are still many challenges that need to be overcome before we can fully utilize genomic markers and targets for cancer prediction, diagnostics, treatment and prognostics. This review describes recent advances in comprehensive genomic characterization at the DNA level, and considers some of the challenges that remain for defining the precise genomic portrait of tumors. Potential solutions that may help overcome these challenges are also offered. |
DOI | 10.1586/14737159.6.1.39 |
Alternate Journal | Expert Rev. Mol. Diagn. |
PubMed ID | 16359266 |
Grant List | K22 DE014847 / DE / NIDCR NIH HHS / United States R01 AI52737 / AI / NIAID NIH HHS / United States R01 DE015970-01 / DE / NIDCR NIH HHS / United States R03 CA114688 / CA / NCI NIH HHS / United States R03 DE016569 / DE / NIDCR NIH HHS / United States R21 AI49135 / AI / NIAID NIH HHS / United States R21 CA97771 / CA / NCI NIH HHS / United States |